Chronic propranolol treatment affects expression of adrenoceptors on peritoneal macrophages and their ability to produce hydrogen peroxide and nitric oxide

Journal of Neuroimmunology

Volumn 211, Issue 1-2, 2009, Pages 56-65

  Dimitrijević, Mirjana ^a   Pilipović, Ivan ^a   Stanojević, Stanislava ^a   Mitić, Katarina ^a   Radojević, Katarina ^a   Pešić, Vesna ^b   Leposavić, Gordana ^a,b  

^a Institute of Virology Vaccines and Sera Torlak   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

adrenoceptor; adrenoceptor; Catecholamines; Macrophages; Rat

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; HYDROGEN PEROXIDE; NITRIC OXIDE; NORADRENALIN; PROPRANOLOL; TYROSINE 3 MONOOXYGENASE; URAPIDIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE SYNTHESIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLOW CYTOMETRY; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; TYROSINE 3-MONOOXYGENASE;

EID: 67349256113     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.014     Document Type: Article

References (58)

1. Aarons R.D., Nies A.S., Gal J., Hegstrand L.R., and Molinoff P.B. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J. Clin. Invest. 65 (1980) 949-957
2. Abrass C.K., O'Connor S.W., Scarpace P.J., and Abrass I.B. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J. Immunol. 135 (1985) 1338-1341
3. Bellinger D.L., Millar B.A., Perez S., Carter J., Wood C., ThyagaRajan S., Molinaro C., Lubahn C., and Lorton D. Sympathetic modulation of immunity: relevance to disease. Cell. Immunol. 252 (2008) 27-56
4. Bernard A.C., Fitzpatrick E.A., Maley M.E., Gellin G.L., Tsuei B.J., Arden W.A., Boulanger B.R., Kearney P.A., and Ochoa J.B. Beta adrenoceptor regulation of macrophage arginase activity. Surgery 127 (2000) 412-418
5. Boost K.A., Flondor M., Hofstetter C., Platacis I., Stegewerth K., Hoegl S., Nguyen T., Muhl H., and Zwissler B. The beta-adrenoceptor antagonist propranolol counteracts anti-inflammatory effects of isoflurane in rat endotoxemia. Acta Anaesthesiol. Scand. 51 (2007) 900-908
6. Brown S.W., Meyers R.T., Brennan K.M., Rumble J.M., Narasimhachari N., Perozzi E.F., Ryan J.J., Stewart J.K., and Fischer-Stenger K. Catecholamines in a macrophage cell line. J. Neuroimmunol. 135 (2003) 47-55
7. Chi D.S., Qui M., Krishnaswamy G., Li C., and Stone W. Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8 (2003) 127-132
8. Conlon M.M. Interaction analysis: a therapeutic tool. Br. J. Nurs. 4 (1995) 1269-1272
9. Day M.D., Poyser R.H., and Sempik J. Effects on blood pressure of noradrenaline and isoprenaline administered into the third ventricle of the brain of anaesthetized and conscious cats. J. Auton. Pharmacol. 1 (1980) 37-43
10. Drath D.B. Enhanced superoxide release and tumoricidal activity by a postlavage, in situ pulmonary macrophage population in response to activation by Mycobacterium bovis BCG exposure. Infect. Immun. 49 (1985) 72-75
11. Elayan H., Kennedy B., and Ziegler M.G. Propranolol reduces rat dopamine-beta-hydroxylase activity and catecholamine levels. Eur. J. Pharmacol. 212 (1992) 259-262
12. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
13. Engler K.L., Rudd M.L., Ryan J.J., Stewart J.K., and Fischer-Stenger K. Autocrine actions of macrophage-derived catecholamines on interleukin-1 beta. J. Neuroimmunol. 160 (2005) 87-91
14. Fallman M., Andersson R., and Andersson T. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles. J. Immunol. 151 (1993) 330-338
15. Garcìa J.J., del Carmen Saez M., De la Fuente M., and Ortega E. Regulation of phagocytic process of macrophages by noradrenaline and its end metabolite 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-adrenoreceptors. Mol. Cell. Biochem. 254 (2003) 299-304
16. Glaubiger G., and Lefkowitz R.J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem. Biophys. Res. Commun. 78 (1977) 720-725
17. Gorgani N.N., Ma Y., and Clark H.F. Gene signatures reflect the marked heterogeneity of tissue-resident macrophages. Immunol. Cell Biol. 86 (2008) 246-254
18. Gosain A., Muthu K., Gamelli R.L., and DiPietro L.A. Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha- and beta-adrenoreceptor dependent pathways. Surgery 142 (2007) 170-179
19. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
20. Haeusler G. Pharmacology of beta-blockers: classical aspects and recent developments. J. Cardiovasc. Pharmacol. 16 Suppl 5 (1990) S1-S9
21. Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., and Szabo C. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br. J. Pharmacol. 125 (1998) 1297-1303
22. Hasko G., Szabo C., Nemeth Z.H., and Deitch E.A. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J. Neuroimmunol. 122 (2002) 34-39
23. Hedberg A., Gerber J.G., Nies A.S., Wolfe B.B., and Molinoff P.B. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J. Pharmacol. Exp. Ther. 239 (1986) 117-123
24. Ignatowski T.A., Kunkel S.L., and Spengler R.N. Interactions between the alpha(2)-adrenergic and the prostaglandin response in the regulation of macrophage-derived tumor necrosis factor. Clin. Immunol. 96 (2000) 44-51
25. Itoh C.E., Kizaki T., Hitomi Y., Hanawa T., Kamiya S., Ookawara T., Suzuki K., Izawa T., Saitoh D., Haga S., and Ohno H. Down-regulation of beta2-adrenergic receptor expression by exercise training increases IL-12 production by macrophages following LPS stimulation. Biochem. Biophys. Res. Commun. 322 (2004) 979-984
26. Izeboud C.A., Mocking J.A., Monshouwer M., van Miert A.S., and Witkamp R.F. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J. Recept. Signal Transduct. Res. 19 (1999) 191-202
27. Josefsson E., Bergquist J., Ekman R., and Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88 (1996) 140-146
28. Kamath A.B., Nagarkatti P.S., and Nagarkatti M. Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol. Appl. Pharmacol. 150 (1998) 117-124
29. Kavelaars A. Regulated expression of alpha-1 adrenergic receptors in the immune system. Brain Behav. Immun. 16 (2002) 799-807
30. Lavand'homme P.M., Ma W., De Kock M., and Eisenach J.C. Perineural alpha(2A)-adrenoceptor activation inhibits spinal cord neuroplasticity and tactile allodynia after nerve injury. Anesthesiology 97 (2002) 972-980
31. Leposavic G., Radojevic K., Vidic-Dankovic B., Kosec D., Pilipovic I., and Perisic M. Early postnatal castration affects thymic and thymocyte noradrenaline levels and beta-adrenoceptor-mediated influence on the thymopoiesis in adult rats. J. Neuroimmunol. 182 (2007) 100-115
32. Lewis P.J. beta-receptor-blockade hypotension and the central nervous system. Clin. Sci. Mol. Med. Suppl. 3 (1976) 549s-556s
33. Lin W.C., Tsai P.S., and Huang C.J. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth. Analg. 101 (2005) 226-232
34. Madden K.S., and Felten D.L. Experimental basis for neural-immune interactions. Physiol. Rev. 75 (1995) 77-106
35. Michel M.C., Pingsmann A., Beckeringh J.J., Zerkowski H.R., Doetsch N., and Brodde O.E. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Br. J. Pharmacol. 94 (1988) 685-692
36. Miida H., Arakawa S., Shibaya Y., Honda K., Kiyosawa N., Watanabe K., Manabe S., Takasaki W., and Ueno K. Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR). J. Toxicol. Sci. 33 (2008) 349-361
37. Mora F., Lee T.F., and Myers R.D. Involvement of alpha- and beta-adrenoreceptors in the central action of norepinephrine on temperature, metabolism, heart and respiratory rates of the conscious primate. Brain Res. Bull. 11 (1983) 613-616
38. Morio L.A., Chiu H., Sprowles K.A., and Laskin D.L. Functional heterogeneity of rat hepatic and alveolar macrophages: effects of chronic ethanol administration. J. Leukoc. Biol. 68 (2000) 614-620
39. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 73 (2003) 209-212
40. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 21 (2007) 736-745
41. Neil-Dwyer G., Bartlett J., McAinsh J., and Cruickshank J.M. Beta-adrenoceptor blockers and the blood-brian barrier. Br. J. Clin. Pharmacol. 11 (1981) 549-553
42. Ortega E., Giraldo E., Hinchado M.D., Martin L., Garcìa J.J., and De la Fuente M. Neuroimmunomodulation during exercise: role of catecholamines as 'stress mediator' and/or 'danger signal' for the innate immune response. Neuroimmunomodulation 14 (2007) 206-212
43. Pick E., Charon J., and Mizel D. A rapid densitometric microassay for nitroblue tetrazolium reduction and application of the microassay to macrophages. J. Reticuloendothel. Soc. 30 (1981) 581-593
44. Pick E., and Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 46 (1981) 211-226
45. Radojcic T., Baird S., Darko D., Smith D., and Bulloch K. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 30 (1991) 328-335
46. Rao T.S., Correa L.D., Adams P., Santori E.M., and Sacaan A.I. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists. Brain Res. 990 (2003) 203-208
47. Rouppe van der Voort C., Heijnen C.J., Wulffraat N., Kuis W., and Kavelaars A. Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors. J. Neuroimmunol. 110 (2000) 223-229
48. Rouppe van der Voort C., Kavelaars A., van de Pol M., and Heijnen C.J. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha(1)-adrenergic receptors. J. Neuroimmunol. 108 (2000) 82-91
49. Saez M.C., Garcìa J.J., De la Fuente M., and Ortega E. Modulation of superoxide anion levels of macrophages from young-adult and old mice by the norepinephrine metabolite, 4-hydroxy-3-methoxyphenyl-glycol. Exp. Gerontol. 37 (2002) 395-400
50. Shen H.M., Sha L.X., Kennedy J.L., and Ou D.W. Adrenergic receptors regulate macrophage secretion. Int. J. Immunopharmacol. 16 (1994) 905-910
51. Sigola L.B., and Zinyama R.B. Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors. Immunology 100 (2000) 359-363
52. Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., and Kunkel S.L. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152 (1994) 3024-3031
53. Stout R.D., and Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76 (2004) 509-513
54. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., and Baud L. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur. J. Immunol. 26 (1996) 2601-2605
55. Sun J., Kim S.J., Park M.K., Kim H.J., Tsoy I., Kang Y.J., Lee Y.S., Seo H.G., Lee J.H., and Chang K.C. Selective activation of adrenergic beta1 receptors induces heme oxygenase 1 production in RAW264.7 cells. FEBS Lett. 579 (2005) 5494-5500
56. Szelenyi J., Kiss J.P., and Vizi E.S. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J. Neuroimmunol. 103 (2000) 34-40
57. Tsao C.W., Lin Y.S., and Cheng J.T. Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci. 62 (1998) PL 335-344.
58. van den Berg T.K., Dopp E.A., and Dijkstra C.D. Rat macrophages: membrane glycoproteins in differentiation and function. Immunol. Rev. 184 (2001) 45-57